Cargando…

Purification of a Multidrug Resistance Transporter for Crystallization Studies

Crystallization of integral membrane proteins is a challenging field and much effort has been invested in optimizing the overexpression and purification steps needed to obtain milligram amounts of pure, stable, monodisperse protein sample for crystallography studies. Our current work involves the st...

Descripción completa

Detalles Bibliográficos
Autores principales: Alegre, Kamela O., Law, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790320/
https://www.ncbi.nlm.nih.gov/pubmed/27025617
http://dx.doi.org/10.3390/antibiotics4010113
_version_ 1782420973352386560
author Alegre, Kamela O.
Law, Christopher J.
author_facet Alegre, Kamela O.
Law, Christopher J.
author_sort Alegre, Kamela O.
collection PubMed
description Crystallization of integral membrane proteins is a challenging field and much effort has been invested in optimizing the overexpression and purification steps needed to obtain milligram amounts of pure, stable, monodisperse protein sample for crystallography studies. Our current work involves the structural and functional characterization of the Escherichia coli multidrug resistance transporter MdtM, a member of the major facilitator superfamily (MFS). Here we present a protocol for isolation of MdtM to increase yields of recombinant protein to the milligram quantities necessary for pursuit of structural studies using X-ray crystallography. Purification of MdtM was enhanced by introduction of an elongated His-tag, followed by identification and subsequent removal of chaperonin contamination. For crystallization trials of MdtM, detergent screening using size exclusion chromatography determined that decylmaltoside (DM) was the shortest-chain detergent that maintained the protein in a stable, monodispersed state. Crystallization trials of MdtM performed using the hanging-drop diffusion method with commercially available crystallization screens yielded 3D protein crystals under several different conditions. We contend that the purification protocol described here may be employed for production of high-quality protein of other multidrug efflux members of the MFS, a ubiquitous, physiologically and clinically important class of membrane transporters.
format Online
Article
Text
id pubmed-4790320
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-47903202016-03-24 Purification of a Multidrug Resistance Transporter for Crystallization Studies Alegre, Kamela O. Law, Christopher J. Antibiotics (Basel) Article Crystallization of integral membrane proteins is a challenging field and much effort has been invested in optimizing the overexpression and purification steps needed to obtain milligram amounts of pure, stable, monodisperse protein sample for crystallography studies. Our current work involves the structural and functional characterization of the Escherichia coli multidrug resistance transporter MdtM, a member of the major facilitator superfamily (MFS). Here we present a protocol for isolation of MdtM to increase yields of recombinant protein to the milligram quantities necessary for pursuit of structural studies using X-ray crystallography. Purification of MdtM was enhanced by introduction of an elongated His-tag, followed by identification and subsequent removal of chaperonin contamination. For crystallization trials of MdtM, detergent screening using size exclusion chromatography determined that decylmaltoside (DM) was the shortest-chain detergent that maintained the protein in a stable, monodispersed state. Crystallization trials of MdtM performed using the hanging-drop diffusion method with commercially available crystallization screens yielded 3D protein crystals under several different conditions. We contend that the purification protocol described here may be employed for production of high-quality protein of other multidrug efflux members of the MFS, a ubiquitous, physiologically and clinically important class of membrane transporters. MDPI 2015-03-05 /pmc/articles/PMC4790320/ /pubmed/27025617 http://dx.doi.org/10.3390/antibiotics4010113 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alegre, Kamela O.
Law, Christopher J.
Purification of a Multidrug Resistance Transporter for Crystallization Studies
title Purification of a Multidrug Resistance Transporter for Crystallization Studies
title_full Purification of a Multidrug Resistance Transporter for Crystallization Studies
title_fullStr Purification of a Multidrug Resistance Transporter for Crystallization Studies
title_full_unstemmed Purification of a Multidrug Resistance Transporter for Crystallization Studies
title_short Purification of a Multidrug Resistance Transporter for Crystallization Studies
title_sort purification of a multidrug resistance transporter for crystallization studies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790320/
https://www.ncbi.nlm.nih.gov/pubmed/27025617
http://dx.doi.org/10.3390/antibiotics4010113
work_keys_str_mv AT alegrekamelao purificationofamultidrugresistancetransporterforcrystallizationstudies
AT lawchristopherj purificationofamultidrugresistancetransporterforcrystallizationstudies